Education
About Us
Working with TipRanks
Follow Us
Rafael Holdings Inc (RFL)
NYSE:RFL
RFL Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.27 - $3.19
Previous CloseN/A
Volume21.81K
Average Volume (3M)300.99K
Market Cap
$101.77M
Enterprise Value$277.72M
Total Cash (Recent Filing)$37.94M
Total Debt (Recent Filing)$690.00K
Price to Earnings (P/E)―
Beta0.61
Next Earnings
Nov 03, 2025EPS EstimateN/A
Last Dividend Ex-Date
Dec 18, 2009Dividend YieldN/A
Share Statistics
EPS (TTM)-0.19
Shares Outstanding50,088,024
10 Day Avg. Volume721,910
30 Day Avg. Volume300,990
Financial Highlights & Ratios
PEG Ratio0.25
Price to Book (P/B)0.46
Price to Sales (P/S)0.00
P/FCF Ratio1.14
Enterprise Value/Market Cap2.73
Enterprise Value/Revenue100.19
Enterprise Value/Gross Profit498.60
Enterprise Value/Ebitda-1.06
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Rafael Holdings News
PremiumCompany Announcements
Rafael Holdings Advances Phase 3 Study for NPC1 Treatment
PremiumCompany Announcements
Rafael Holdings Reports Improved Financial Results and Strategic Progress
PremiumCompany Announcements
Rafael Holdings Completes $25M Rights OfferingPremiumCompany Announcements
Rafael Holdings Enters Standby Purchase Agreement with Chairman
Options Prices
Currently, No data available
---
Ownership Overview
31.90% Insiders
2.86% Mutual Funds
1.50% Other Institutional Investors
61.27% Public Companies and
Individual Investors
RFL FAQ
What was Rafael Holdings Inc’s price range in the past 12 months?
Rafael Holdings Inc lowest stock price was $1.27 and its highest was $3.19 in the past 12 months.
What is Rafael Holdings Inc’s market cap?
Rafael Holdings Inc’s market cap is $101.77M.
When is Rafael Holdings Inc’s upcoming earnings report date?
Rafael Holdings Inc’s upcoming earnings report date is Nov 03, 2025 which is in 137 days.
How were Rafael Holdings Inc’s earnings last quarter?
Rafael Holdings Inc released its earnings results on Jun 11, 2025. The company reported -$0.187 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.187.
Is Rafael Holdings Inc overvalued?
According to Wall Street analysts Rafael Holdings Inc’s price is currently Overvalued.
Does Rafael Holdings Inc pay dividends?
Rafael Holdings Inc pays a Semiannually dividend of $0.02 which represents an annual dividend yield of N/A. See more information on Rafael Holdings Inc dividends here
What is Rafael Holdings Inc’s EPS estimate?
Rafael Holdings Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rafael Holdings Inc have?
Rafael Holdings Inc has 50,088,024 shares outstanding.
What happened to Rafael Holdings Inc’s price movement after its last earnings report?
Rafael Holdings Inc reported an EPS of -$0.187 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -27.719%.
Which hedge fund is a major shareholder of Rafael Holdings Inc?
Currently, no hedge funds are holding shares in RFL
Rafael Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 5.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $16.9M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
32.96%
12-Months-Change
Fundamentals
Return on Equity
-27.47%
Trailing 12-Months
Asset Growth
6.37%
Trailing 12-Months
Company Description
Rafael Holdings Inc
Rafael Holdings, Inc. holds interests in clinical and early stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. The company operates in two segments, Pharmaceuticals and Real Estate. It engages in the leasing of a commercial office building, as well as an associated 800-car public garage; and development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company's lead drug candidate is CPI-613 (devimistat), which is being evaluated in various clinical studies, including two Phase III registrational clinical trials for the treatment of metastatic pancreatic cancer and r/r acute myeloid leukemia. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.
Technical Analysis
Comstock Mining
―
Manhattan Bridge Capital
―
Clipper Realty
―
Sachem Capital
―
Global Self Storage
―